MEGASPHERE
Dead / Cancelled — Cancelled — Section 8 (as of 28 Oct 2022)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 77097275
- Registration number
- 4128938
- Mark type
- Stylized text
- Filed
- 01 Feb 2007
- Published for opposition
- 25 Nov 2008
- Registered
- 17 Apr 2012
- Attorney of record
- Ian W. Gillies
Goods and services
- Class 003 — Cosmetics and cleaning preparations: Transdermal delivery composition sold as a component ingredient for cosmetic agents, namely, skin brightener, age spots reducer, skin discolorations reducer, stretch mark reducer, spider veins reducer, skin tightness restorer, skin flexibility restorer, dyes, inks, perfume, fragrance, collagen, collagen fragment, proteoglycan, mucopolysaccharide, glycosaminoglycan, protein, peptide, sugar, nucleic acid, lipid, ceramide
- Class 005 — Pharmaceuticals: Transdermal delivery composition for pharmaceutical agents, namely, pain reliever, muscle relaxers, wound healing formulation, growth factor product, and anti-psoriasis product, anti-eczema product, hormone replacement product, hormone, peptide hormone, non-peptide hormone, steroidal hormone, anesthetic, analgesics, non-steroidal anti-inflammatory drug, COX enzyme inhibitor, steroidal anti-inflammatory compound, migraine therapy, capsaicin, beta-boswellic acids, glycerin-butylene glycol-arctostaphylos Uva Ursi leaf extract-Mitracarpus Scaber extract, palmitoyl pentapeptide-3, sedative, anti-infective agent, antibiotic, antiviral, muscle relaxant, burn treatment product, anti-oxidative stress product, antioxidant, chemotherapeutic agent, immunogen, immune adjuvant, immunogenic composition, immunogenic peptide, nucleic acid-based immunogens, vaccine, immune response modifier, imaging compound, contrast compound, cardiovascular pharmaceutical compound, diabetes-related treatment compound, enzyme inhibitor, collagens, collagen fragment, glucosamine, chondroitin sulfate, MSM, melasin, nicotine, nicotine analog, humate, therapeutic antibody, transport globulin, cytokine biosynthesis modifier, collagen, collagen fragment, proteoglycan, mucopolysaccharide, glycosaminoglycan, nucleic acid, polynucleotide, protein, peptide, amino acid, peptidomimetic, sugar, lipid, glycoprotein, ceramide
Owner
- JRX BIOTECHNOLOGY, INC., Orange, CA, US
- JRX BIOTECHNOLOGY, INC., Orange, CA, US
- JRX BIOTECHNOLOGY, INC., NEWPORT BEACH, CA, US
- JRX BIOTECHNOLOGY, INC., NEWPORT BEACH, CA, US
- JORDAN RESEARCH HOLDINGS, NEWPORT BEACH, CA, US
- JORDAN RESEARCH HOLDINGS, NEWPORT BEACH, CA, US
- ORYXE, Irvine, CA, US
- ORYXE, Irvine, CA, US
- ORYXE, Irvine, CA, US
- ORYXE, Irvine, CA, US
Prosecution history
- 28 Oct 2022 — CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
- 21 Sept 2021 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 21 Sept 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 21 Sept 2021 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 21 Sept 2021 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 21 Sept 2021 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 17 Apr 2021 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 30 Oct 2018 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 30 Oct 2018 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 30 Oct 2018 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 15 Oct 2018 — TEAS SECTION 8 & 15 RECEIVED
- 17 Apr 2017 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 17 Apr 2012 — REGISTERED-PRINCIPAL REGISTER
- 13 Mar 2012 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 10 Mar 2012 — LAW OFFICE REGISTRATION REVIEW COMPLETED